NASDAQ:FWP - Forward Pharma A/S Stock Price, News, & Analysis

0.00 (0.00 %)
(As of 06/19/2019 03:33 AM ET)
Today's Range
Now: $0.98
50-Day Range
MA: $1.00
52-Week Range
Now: $0.98
Volume3,312 shs
Average Volume13,930 shs
Market Capitalization$46.24 million
P/E RatioN/A
Dividend YieldN/A
Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolNASDAQ:FWP



Sales & Book Value

Annual Sales$1.25 billion
Book Value$1.74 per share



Market Cap$46.24 million
Next Earnings DateN/A
OptionableNot Optionable

Receive FWP News and Ratings via Email

Sign-up to receive the latest news and ratings for FWP and its competitors with MarketBeat's FREE daily newsletter.

Forward Pharma A/S (NASDAQ:FWP) Frequently Asked Questions

What is Forward Pharma A/S's stock symbol?

Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

How were Forward Pharma A/S's earnings last quarter?

Forward Pharma A/S (NASDAQ:FWP) issued its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06. View Forward Pharma A/S's Earnings History.

Has Forward Pharma A/S been receiving favorable news coverage?

News coverage about FWP stock has trended very negative this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Forward Pharma A/S earned a coverage optimism score of -3.1 on InfoTrie's scale. They also gave press coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for Forward Pharma A/S.

Who are some of Forward Pharma A/S's key competitors?

What other stocks do shareholders of Forward Pharma A/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Celldex Therapeutics (CLDX), Gilead Sciences (GILD), Micron Technology (MU), Novartis (NVS), MOTIF BIO PLC/S (MTFB), Novavax (NVAX), Portola Pharmaceuticals (PTLA), SCYNEXIS (SCYX), AbbVie (ABBV) and Broadcom (AVGO).

Who are Forward Pharma A/S's key executives?

Forward Pharma A/S's management team includes the folowing people:
  • Mr. Florian Schonharting, Co-Founder & Chairman (Age 50)
  • Dr. Claus Bo Svendsen, CEO & Principal Financial Officer (Age 42)
  • Mr. Thomas Carbone, Principal Accounting Officer (Age 62)

How do I buy shares of Forward Pharma A/S?

Shares of FWP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Forward Pharma A/S's stock price today?

One share of FWP stock can currently be purchased for approximately $0.98.

How big of a company is Forward Pharma A/S?

Forward Pharma A/S has a market capitalization of $46.24 million and generates $1.25 billion in revenue each year. Forward Pharma A/S employs 5 workers across the globe.View Additional Information About Forward Pharma A/S.

What is Forward Pharma A/S's official website?

The official website for Forward Pharma A/S is

How can I contact Forward Pharma A/S?

Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The biotechnology company can be reached via phone at 0114533444242 or via email at [email protected]

MarketBeat Community Rating for Forward Pharma A/S (NASDAQ FWP)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  226 (Vote Outperform)
Underperform Votes:  153 (Vote Underperform)
Total Votes:  379
MarketBeat's community ratings are surveys of what our community members think about Forward Pharma A/S and other stocks. Vote "Outperform" if you believe FWP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe FWP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/19/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel